Congress Considering Legislation Aimed at Increasing Competition in Pharmaceuticals
Year of publication: |
2020
|
---|---|
Authors: | Holman, Christopher M. |
Publisher: |
[2020]: [S.l.] : SSRN |
Subject: | Pharmaindustrie | Pharmaceutical industry | Arzneimittel | Pharmaceuticals | Wettbewerb | Competition | Internationaler Wettbewerb | International competition | Wettbewerbspolitik | Competition policy |
Extent: | 1 Online-Ressource (15 p) |
---|---|
Type of publication: | Book / Working Paper |
Language: | English |
Notes: | In: Biotechnology Law Report, 2019 Nach Informationen von SSRN wurde die ursprüngliche Fassung des Dokuments May 1, 2019 erstellt |
Source: | ECONIS - Online Catalogue of the ZBW |
-
Bad medicine : litigation, competition, and the marketing of prescription opioids
Tan, David, (2023)
-
Designing pro-health competition policies in developing countries
Ido, Vitor Henrique Pinto, (2020)
-
Paying off the competition : market power and innovation incentives
Li, Xuelin, (2021)
- More ...
-
Antibody Claims and the Evolution of the Written Description / Enablement Requirement
Tu, S. Sean, (2022)
-
Biotechnology's Prescription for Patent Reform
Holman, Christopher M., (2014)
-
Do Reverse Payment Settlements Violate the Antitrust Laws?
Holman, Christopher M., (2013)
- More ...